RKDAConsumer Defensive · Packaged FoodsRKDA Stock Forecast: Arcadia Biosciences, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 19 of 100 as at 1 Aug 2026 — in the weakest quartile.
RKDA stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Arcadia Biosciences, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (99): Smaller than most of the companies we track.
Value (3): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own Arcadia Biosciences, Inc. — and when they’d sell — is the membership.
RKDA stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on RKDA, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Of the 19 most recent actions, 1 moved their price target up and 5 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 21 Aug 2024 | HC Wainwright & Co. | Reiterates | Buy | $6.00 |
| 21 Aug 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 23 May 2024 | HC Wainwright & Co. | Maintains | Buy | — |
| 5 Apr 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 28 Aug 2023 | HC Wainwright & Co. | Maintains | Buy | — |
| 24 July 2023 | HC Wainwright & Co. | Reiterates | Buy | — |
| 5 June 2023 | HC Wainwright & Co. | Maintains | Buy | — |
| 14 Apr 2023 | HC Wainwright & Co. | Maintains | Buy | — |
| 26 Aug 2022 | HC Wainwright & Co. | Maintains | Buy | $4.00 → $3.00 |
| 3 Jan 2022 | HC Wainwright & Co. | Maintains | Buy | $7.00 → $6.00 |
| 1 June 2021 | HC Wainwright & Co. | Maintains | Buy | $6.00 → $7.00 |
| 11 May 2021 | Lake Street | Initiates | Buy | — |
| 9 Feb 2021 | HC Wainwright & Co. | Maintains | Buy | $8.00 → $6.00 |
| 30 Nov 2020 | HC Wainwright & Co. | Maintains | Buy | $12 → $10 |
| 17 Aug 2020 | HC Wainwright & Co. | Maintains | Buy | $14 → $12 |
| 20 June 2018 | H.C. Wainwright | Initiates | Buy | — |
| 19 June 2018 | H.C. Wainwright | Initiates | Buy | — |
| 12 May 2017 | PiperJaffray | Downgrade | Neutral | — |
| 9 June 2015 | Credit Suisse | Initiates | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
RKDA analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Arcadia Biosciences, Inc. (RKDA) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −0.4×
- Price / sales
- 0.3×
- Price / book
- 0.5×
- EV / EBITDA
- 0.5×
Cheaper than 79% of US stocks
Cheaper than 89% of US stocks
Cheaper than 85% of US stocks
Cheaper than 59% of US stocks
- Revenue growth (YoY)
- −8.3%
- Earnings growth (YoY)
- −8.3%
- Gross margin
- 36.4%
- Operating margin
- −70.8%
- Net margin
- −195.9%
Higher than 17% of US stocks
Higher than 27% of US stocks
Higher than 46% of US stocks
Higher than 16% of US stocks
Higher than 2% of US stocks
- Return on equity
- −158.2%
- Return on assets
- −32.8%
- Dividend yield
- —
Higher than 8% of US stocks
Higher than 13% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
RKDA vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. RKDA appears on the weeks it earns a place.
Frequently asked questions about RKDA stock
Is RKDA stock a buy right now?
Of the 1 analysts covering Arcadia Biosciences, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Arcadia Biosciences, Inc. 19 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank RKDA?
As at 1 Aug 2026, Arcadia Biosciences, Inc. ranks 19 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (99 of 100).
What is the RKDA stock forecast for 2030?
No analyst covering Arcadia Biosciences, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RKDA are extrapolating price history, which says nothing about the business.
How has RKDA stock performed over the past year?
Arcadia Biosciences, Inc. returned -84.3% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Arcadia Biosciences, Inc. do?
Arcadia Biosciences Inc. is a biotechnology company that focuses on developing and commercializing innovative agricultural products to enhance crop productivity and environmental sustainability.
About Arcadia Biosciences, Inc.
Arcadia Biosciences Inc. is a biotechnology company that focuses on developing and commercializing innovative agricultural products to enhance crop productivity and environmental sustainability. Arcadia specializes in creating proprietary technology that improves crop quality and yield, addressing challenges such as nutritional enhancement, abiotic stress tolerance, and other genetic improvements critical for global food production. The company's work spans multiple crops, including wheat, soybean, and hemp, impacting sectors like food manufacturing, health and wellness, and environmentally sustainable farming practices. By leveraging advanced tools in plant genetic innovation, Arcadia Biosciences plays a significant role in the agricultural supply chain, contributing to reduced environmental impact and improved crop outcomes for growers worldwide. Based in the United States, Arcadia collaborates with leading agricultural companies and institutions to bring cutting-edge solutions to the market, emphasizing its commitment to enhancing food security and sustainability in the global agriculture ecosystem.
CEO Mr. Thomas J. Schaefer C.F.A. · 8 employees · United States · https://arcadiabio.com